Works matching IS 03065251 AND DT 2025 AND VI 91 AND IP 5

Results: 25

Correction to "Incidence and trend of cardiac events among children and young adults exposed to psychopharmacological treatment (2006–2018): A nationwide register‐based study".

Published in:: British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1520, doi. 10.1002/bcp.70058
Publication type:: Article

European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low‐sized study populations.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1293, doi. 10.1002/bcp.70048

By:

Bonertz, Andreas;
Drai, Catherine;
Castelnovo, Thomas;
Hartenstein, Diana;
Kaul, Susanne;
Mitrevski, Milica;
Zubeldia, Jose M.

Publication type:

Article

Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1511, doi. 10.1002/bcp.70047

By:

Wu, Annie Siyu;
Mozessohn, Lee;
Kim, Richard B.;
Zipursky, Jonathan S.

Publication type:

Article

Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1297, doi. 10.1002/bcp.70046

By:

Giunchi, Valentina;
Fusaroli, Michele;
Cangini, Agnese;
Fortinguerra, Filomena;
Zito, Simona;
Pierantozzi, Andrea;
Lunghi, Carlotta;
Poluzzi, Elisabetta;
Trotta, Francesco

Publication type:

Article

Methotrexate toxicity and glucarpidase: A call for dose optimization.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1289, doi. 10.1002/bcp.70044

By:

Koppen, Arjen;
Sikma, Maaike A.;
Engels, Frederike K.;
Heerma van Voss, Marise R.;
Chamuleau, Martine E. D.;
Bartelink, Imke H.;
Dijkman, Marieke A.

Publication type:

Article

Factors influencing physicians' antimicrobial prescribing decisions: A systematic review of qualitative studies.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1330, doi. 10.1002/bcp.70011

By:

Reali, Savannah;
Kwang, Yee Chin;
Cho, Jin‐Gun;
Alffenaar, Jan‐Willem;
Aslani, Parisa

Publication type:

Article

Letter to the editor—Response to the article "Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis".

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1518, doi. 10.1002/bcp.70038

By:

Ranjalkar, Jaya;
Wilfred, Premila M.;
Priya, Raja

Publication type:

Article

Letter to the editor concerning the article: 'The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview'.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1516, doi. 10.1002/bcp.70030

By:

Ágh, Tamás;
Eliasson, Lina;
Borah, Bijan

Publication type:

Article

Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1306, doi. 10.1002/bcp.70025

By:

Htet, Htet;
Kyung, Han You;
Burud, Ismail Abdul Sattar;
Jaiprakash, Heethal;
Subramaniam, Thiruselvi;
Iezhitsa, Igor;
Agarwal, Renu

Publication type:

Article

Safety and effectiveness of the anti‐amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1352, doi. 10.1002/bcp.70021

By:

Bobbins, Amy;
Davies, Miranda;
Lynn, Elizabeth;
Roy, Debabrata;
Yeomans, Alison;
Shakir, Saad A. W.

Publication type:

Article

Janus kinase inhibitors for the treatment of lichen Sclerosus: A systematic review.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1322, doi. 10.1002/bcp.70042

By:

Shen, Chin‐Hsuan;
Wang, Tzu‐Yu;
Chi, Ching‐Chi

Publication type:

Article

Evolving trends in acid suppression therapy among patients undergoing dual antiplatelet therapy: A Nationwide study in South Korea from 2018 to 2022.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1491, doi. 10.1111/bcp.16398

By:

Lee, Yu Jeong;
Je, Nam Kyung

Publication type:

Article

A review on the role of extrapolation as basis for paediatric marketing authorization applications of medicines in the EU.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1500, doi. 10.1111/bcp.16395

By:

Simons, Charlotte W. M.;
Maton, Loes C. H.;
van Dartel, Maaike;
van den Heuvel, Michiel;
den Otter, Loes;
Versantvoort, Carolien;
Colin, Pieter J.;
Koomen, Jeroen V.

Publication type:

Article

Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1479, doi. 10.1111/bcp.16394

By:

Cosson, Valérie;
Fu, Rong;
Kulasekararaj, Austin;
Nishimura, Jun‐Ichi;
Panse, Jens;
Röth, Alexander;
Scheinberg, Phillip;
Tong, Hongyan;
Yoon, Sung‐Soo;
Beveridge, Leigh;
Gotanda, Keisuke;
Jaminion, Félix;
Henrich, Andrea;
Lundberg, Pontus;
Shi, Dayu;
Sreckovic, Sasha;
Zhang, Yuchen;
Zhang, Zilu;
Benkali, Khaled;
Buatois, Simon

Publication type:

Article

Cancer drug applications to the EMA and the FDA: A comparison of new drugs and extension of indication in terms of approval decisions and time in review.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1431, doi. 10.1111/bcp.16391

By:

Cramer, Allan;
Sørup, Freja Karuna Hemmingsen;
Christensen, Hanne Rolighed;
Petersen, Tonny Studsgaard;
Karstoft, Kristian

Publication type:

Article

The efficacy of hydroxychloroquine in paediatric chronic immune thrombocytopenia: A retrospective cohort study.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1449, doi. 10.1111/bcp.16389

By:

Liu, Jing;
Zhang, Yuelun;
Song, Hongmei;
Ma, Mingsheng;
Li, Zhuo;
Zhang, Lejia;
Song, Yuqing;
Lyu, Zichao;
Lu, Yixiu;
Xiao, Juan

Publication type:

Article

Performance of the accelerated assessment of the European Medicines Agency.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1439, doi. 10.1111/bcp.16385

By:

Del Grosso, Vittorio;
Perini, Martina;
Casilli, Giorgio;
Costa, Enrico;
Boscaro, Valentina;
Miglio, Gianluca;
Genazzani, Armando A.

Publication type:

Article

Risk of bias tools for medication adherence research: RoBIAS and RoBOAS.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1457, doi. 10.1111/bcp.16382

By:

Sinnappah, Klarissa A.;
Hughes, Dyfrig A.;
Stocker, Sophie L.;
Wright, Daniel F. B.

Publication type:

Article

Population modelling of nilotinib exposure vs. longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1419, doi. 10.1111/bcp.16381

By:

Sy, Sherwin K. B.;
Yoon, Deok Yong;
Darstein, Christelle;
Yang, Yiqun;
Dasgupta, Kohinoor;
Kapoor, Shruti;
Hoch, Matthias;
Grosch, Kai

Publication type:

Article

Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1409, doi. 10.1111/bcp.16377

By:

Sumimoto, Takahiro;
Tanaka, Ryota;
Murakami, Yuko;
Tatsuta, Ryosuke;
Itoh, Hiroki

Publication type:

Article

Killing several birds with one stone: A multi‐indication population pharmacokinetic model and Bayesian estimator for enteric‐coated mycophenolate sodium.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1396, doi. 10.1111/bcp.16374

By:

Fromage, Yeleen;
Sayadi, Hamza;
Koloskoff, Kevin;
Marquet, Pierre;
Labriffe, Marc;
Monchaud, Caroline;
Woillard, Jean‐Baptiste

Publication type:

Article

Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers<sup>1</sup>.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1361, doi. 10.1111/bcp.16371

By:

Jorgensen, Andrea L.;
Korver, Samantha;
Schofield, Amy;
Howell, Lawrence;
Clarke, Joanna I.;
Walker, Lauren E.;
Brillant, Nathalie;
Goldring, Chris E. P.;
Pirmohamed, Munir

Publication type:

Article

Evaluating the effect of making the indication field compulsory in electronic prescriptions: A pre‐post study in a hospital prescribing system.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1370, doi. 10.1111/bcp.16370

By:

Pairman, Lorna;
Chin, Paul;
Doogue, Matthew

Publication type:

Article

Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1382, doi. 10.1111/bcp.16368

By:

Gloor, Yvonne S.;
Mouterde, Médéric;
Terrier, Jean;
Lenoir, Camille;
Gosselin, Pauline;
Rollason, Victoria;
Reny, Jean‐Luc;
Boukouvala, Sotiria;
Al‐Yahyaee, Said;
Yimer, Getnet;
Černý, Viktor;
Poloni, Estella S.;
Samer, Caroline F.;
Daali, Youssef

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2025, v. 91, n. 5, p. 1287, doi. 10.1111/bcp.16104
Publication type:: Article